Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 64

    1.

    Ovarian cancer risk associated with inherited inflammation-related variants.

    White KL, Schildkraut JM, Palmieri RT, Iversen ES Jr, Berchuck A, Vierkant RA, Rider DN, Charbonneau B, Cicek MS, Sutphen R, Birrer MJ, Pharoah PP, Song H, Tyrer J, Gayther SA, Ramus SJ, Wentzensen N, Yang HP, Garcia-Closas M, Phelan CM, Cunningham JM, Fridley BL, Sellers TA, Goode EL; Ovarian Cancer Association Consortium.

    Cancer Res. 2012 Mar 1;72(5):1064-9. Epub 2012 Jan 26.

    PMID:
    22282663
    [PubMed - indexed for MEDLINE]
    2.

    Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells.

    Arora HC, Jensen MP, Yuan Y, Wu A, Vogt S, Paunesku T, Woloschak GE.

    Cancer Res. 2012 Feb 1;72(3):769-78. Epub 2011 Dec 12.

    PMID:
    22158944
    [PubMed - indexed for MEDLINE]
    3.

    A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.

    Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG, Coward JI, Schioppa T, Robinson SC, Gallagher WM, Galletta L; Australian Ovarian Cancer Study Group, Salako MA, Smyth JF, Hagemann T, Brennan DJ, Bowtell DD, Balkwill FR.

    Cancer Res. 2012 Jan 1;72(1):66-75. Epub 2011 Nov 7.

    PMID:
    22065722
    [PubMed - indexed for MEDLINE]
    4.

    PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.

    Obermajer N, Muthuswamy R, Odunsi K, Edwards RP, Kalinski P.

    Cancer Res. 2011 Dec 15;71(24):7463-70. Epub 2011 Oct 24.

    PMID:
    22025564
    [PubMed - indexed for MEDLINE]
    5.

    TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.

    Sommariva M, De Cecco L, De Cesare M, Sfondrini L, Ménard S, Melani C, Delia D, Zaffaroni N, Pratesi G, Uva V, Tagliabue E, Balsari A.

    Cancer Res. 2011 Oct 15;71(20):6382-90. Epub 2011 Aug 30.

    PMID:
    21878529
    [PubMed - indexed for MEDLINE]
    6.

    ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.

    Guan B, Wang TL, Shih IeM.

    Cancer Res. 2011 Nov 1;71(21):6718-27. Epub 2011 Sep 7.

    PMID:
    21900401
    [PubMed - indexed for MEDLINE]
    7.

    Definition of the landscape of promoter DNA hypomethylation in liver cancer.

    Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, Szyf M.

    Cancer Res. 2011 Sep 1;71(17):5891-903. Epub 2011 Jul 11.

    PMID:
    21747116
    [PubMed - indexed for MEDLINE]
    8.

    Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.

    Bitler BG, Nicodemus JP, Li H, Cai Q, Wu H, Hua X, Li T, Birrer MJ, Godwin AK, Cairns P, Zhang R.

    Cancer Res. 2011 Oct 1;71(19):6184-94. Epub 2011 Aug 4.

    PMID:
    21816908
    [PubMed - indexed for MEDLINE]
    9.

    Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy.

    Hubert P, Heitzmann A, Viel S, Nicolas A, Sastre-Garau X, Oppezzo P, Pritsch O, Osinaga E, Amigorena S.

    Cancer Res. 2011 Aug 1;71(15):5134-43. Epub 2011 Jun 22.

    PMID:
    21697279
    [PubMed - indexed for MEDLINE]
    10.

    Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines.

    Swaminathan V, Mythreye K, O'Brien ET, Berchuck A, Blobe GC, Superfine R.

    Cancer Res. 2011 Aug 1;71(15):5075-80. Epub 2011 Jun 3.

    PMID:
    21642375
    [PubMed - indexed for MEDLINE]
    11.

    Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.

    Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, Antoniou AC, Peock S, Evans DG, Paterson J, Kennedy MJ, Donaldson A, Dorkins H, Easton DF; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Rubinstein WS, Daly MB, Isaacs C, Nevanlinna H, Couch FJ, Andrulis IL, Freidman E, Laitman Y, Ganz PA, Tomlinson GE, Neuhausen SL, Narod SA, Phelan CM, Greenberg R, Nathanson KL.

    Cancer Res. 2011 Sep 1;71(17):5792-805. Epub 2011 Jul 28.

    PMID:
    21799032
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer.

    Darshan MS, Loftus MS, Thadani-Mulero M, Levy BP, Escuin D, Zhou XK, Gjyrezi A, Chanel-Vos C, Shen R, Tagawa ST, Bander NH, Nanus DM, Giannakakou P.

    Cancer Res. 2011 Sep 15;71(18):6019-29. Epub 2011 Jul 28.

    PMID:
    21799031
    [PubMed - indexed for MEDLINE]
    13.

    Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.

    Hu W, Lu C, Dong HH, Huang J, Shen DY, Stone RL, Nick AM, Shahzad MM, Mora E, Jennings NB, Lee SJ, Roh JW, Matsuo K, Nishimura M, Goodman BW, Jaffe RB, Langley RR, Deavers MT, Lopez-Berestein G, Coleman RL, Sood AK.

    Cancer Res. 2011 Sep 15;71(18):6030-9. Epub 2011 Jul 27.

    PMID:
    21795478
    [PubMed - indexed for MEDLINE]
    14.

    Human tumor cells killed by anthracyclines induce a tumor-specific immune response.

    Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Spísek R.

    Cancer Res. 2011 Jul 15;71(14):4821-33. Epub 2011 May 20.

    PMID:
    21602432
    [PubMed - indexed for MEDLINE]
    15.

    CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.

    Righi E, Kashiwagi S, Yuan J, Santosuosso M, Leblanc P, Ingraham R, Forbes B, Edelblute B, Collette B, Xing D, Kowalski M, Mingari MC, Vianello F, Birrer M, Orsulic S, Dranoff G, Poznansky MC.

    Cancer Res. 2011 Aug 15;71(16):5522-34. Epub 2011 Jul 8.

    PMID:
    21742774
    [PubMed - indexed for MEDLINE]
    16.

    Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation.

    Polytarchou C, Iliopoulos D, Hatziapostolou M, Kottakis F, Maroulakou I, Struhl K, Tsichlis PN.

    Cancer Res. 2011 Jul 1;71(13):4720-31. Epub 2011 May 9.

    PMID:
    21555366
    [PubMed - indexed for MEDLINE]
    17.

    In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).

    Song DG, Ye Q, Carpenito C, Poussin M, Wang LP, Ji C, Figini M, June CH, Coukos G, Powell DJ Jr.

    Cancer Res. 2011 Jul 1;71(13):4617-27. Epub 2011 May 5.

    PMID:
    21546571
    [PubMed - indexed for MEDLINE]
    18.

    Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.

    Labidi-Galy SI, Sisirak V, Meeus P, Gobert M, Treilleux I, Bajard A, Combes JD, Faget J, Mithieux F, Cassignol A, Tredan O, Durand I, Ménétrier-Caux C, Caux C, Blay JY, Ray-Coquard I, Bendriss-Vermare N.

    Cancer Res. 2011 Aug 15;71(16):5423-34. Epub 2011 Jun 22.

    PMID:
    21697280
    [PubMed - indexed for MEDLINE]
    19.

    Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.

    Konstantinopoulos PA, Spentzos D, Fountzilas E, Francoeur N, Sanisetty S, Grammatikos AP, Hecht JL, Cannistra SA.

    Cancer Res. 2011 Aug 1;71(15):5081-9. Epub 2011 Jun 15.

    PMID:
    21676886
    [PubMed - indexed for MEDLINE]
    20.

    Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.

    Huehls AM, Wagner JM, Huntoon CJ, Geng L, Erlichman C, Patel AG, Kaufmann SH, Karnitz LM.

    Cancer Res. 2011 Jul 15;71(14):4944-54. Epub 2011 May 25.

    PMID:
    21613406
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk